ProPhase Labs, Inc. announced the approval of multiple stockholder proposals on September 9, 2025, including increasing the number of authorized shares from 50 million to 1 billion and approving two equity incentive plans. The proposals collectively received significant support, with over 63% of shares voted in favor.